logo
COPT Defense Declares Second Quarter 2025 Common Dividend

COPT Defense Declares Second Quarter 2025 Common Dividend

Business Wire20-05-2025

COLUMBIA, Md.--(BUSINESS WIRE)--COPT Defense Properties (NYSE: CDP) ('COPT Defense' or the 'Company') announced today that its Board of Trustees declared a regular quarterly dividend of $0.305 per common share for the second quarter ending June 30, 2025. The second quarter 2025 dividend represents an annualized amount of $1.22 per share and is payable on July 16, 2025, to shareholders of record on June 30, 2025.
In addition, the Company announced the publishing of its eleventh annual Corporate Sustainability Report, along with its fourth annual Task Force on Climate-Related Financial Disclosures ('TCFD') Report. Both reports are available in the 'Sustainability' section of COPT Defense's Investor Relations website (https://investors.copt.com/) and as follows:
2025 Corporate Sustainability Report:
https://d1io3yog0oux5.cloudfront.net/_9cc325f4d3a1f2b0197102d68a0e110a/copt/files/pages/copt/db/2284/description/COPT_SR25_050125_FINAL.pdf
2025 TCFD Report:
https://d1io3yog0oux5.cloudfront.net/_9cc325f4d3a1f2b0197102d68a0e110a/copt/files/pages/copt/db/2284/description/COPT_SR25_TCFD_050125.pdf
About COPT Defense
COPT Defense, an S&P MidCap 400 Company, is a self-managed REIT focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government ('USG') defense installations and missions (referred to as its Defense/IT Portfolio). The Company's tenants include the USG and their defense contractors, who are primarily engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. As of March 31, 2025, the Company's Defense/IT Portfolio of 198 properties, including 24 owned through unconsolidated joint ventures, encompassed 22.6 million square feet and was 96.6% leased.
Forward-Looking Information
This press release may contain 'forward-looking' statements, as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are based on the Company's current expectations, estimates and projections about future events and financial trends affecting the Company. Forward-looking statements can be identified by the use of words such as 'may,' 'will,' 'should,' 'could,' 'believe,' 'anticipate,' 'expect,' 'estimate,' 'plan' or other comparable terminology. Forward-looking statements are inherently subject to risks and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate. Although the Company believes that the expectations, estimates and projections reflected in such forward-looking statements are based on reasonable assumptions at the time made, the Company can give no assurance that these expectations, estimates and projections will be achieved. Future events and actual results may differ materially from those discussed in the forward-looking statements and the Company undertakes no obligation to update or supplement any forward-looking statements.
The areas of risk that may affect these expectations, estimates and projections include, but are not limited to, those risks described in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2024.
Source: COPT Defense Properties

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lazard Opens New UK Headquarters in Historic Manchester Square, W1
Lazard Opens New UK Headquarters in Historic Manchester Square, W1

Business Wire

timean hour ago

  • Business Wire

Lazard Opens New UK Headquarters in Historic Manchester Square, W1

LONDON--(BUSINESS WIRE)--Lazard, Inc. (NYSE: LAZ) announced today that its new UK headquarters opened at 20 Manchester Square, housing both the firm's Financial Advisory and Asset Management businesses. The new, larger office reflects Lazard's commitment to London as one of the world's leading financial centres and the firm's continued growth in Europe. 20 Manchester Square will become part of Lazard's European footprint and one of its three main global offices, alongside New York and Paris. As a cornerstone of Lazard's international network, the new UK HQ extends the firm's long-standing presence in London which dates back to 1877. Cyrus Kapadia, Co-Head of European Investment Banking and CEO of UK Financial Advisory, said: "The move to 20 Manchester Square underscores our unwavering commitment to the UK and our deep-rooted heritage in London. We have been successfully growing our European teams and network to further support our clients across Europe and around the globe." Jeremy Taylor, CEO of Lazard UK Asset Management said, '20 Manchester Square is more than just a new office—it's a reflection of our values and vision. We are committed to delivering exceptional performance for our clients. This new UK headquarters embodies our dedication to innovation, collaboration, and thoughtful stewardship as we continue to best serve the needs of our clients.' The new building offers modern office space and has been designed with an emphasis on innovation and sustainable standards of construction, technology and use. The space has renewable energy from solar panels on the roof and a rainwater harvesting system. The building's construction adhered to the UK Green Building Council framework for net-zero carbon emissions and recycled, long-life materials with reduced replaceability have been used across floors, walls and ceiling finishes, with water efficient taps, showers and fixtures in place throughout. 20 Manchester Square is situated next door to the Wallace Collection and Regent's Park, and the area is well known for its cultural landmarks and accessible transport links. Lazard UK is relocating from 50 Stratton Street, after over twenty years. ABOUT LAZARD Founded in 1848, Lazard is the preeminent financial advisory and asset management firm, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit and follow Lazard on LinkedIn.

Morgans Keeps Their Hold Rating on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN)
Morgans Keeps Their Hold Rating on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN)

Business Insider

timean hour ago

  • Business Insider

Morgans Keeps Their Hold Rating on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN)

Morgans analyst Tom Sartor maintained a Hold rating on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN – Research Report) today and set a price target of A$0.13. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sartor is a 4-star analyst with an average return of 17.9% and a 45.12% success rate. Sartor covers the Basic Materials sector, focusing on stocks such as Sandfire Resources Limited, Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh, and Adriatic Metals Shs Chess Deposit Interests Repr 1 Sh. Currently, the analyst consensus on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh is a Hold with an average price target of A$0.23.

Bernstein Keeps Their Hold Rating on Pfizer (PFE)
Bernstein Keeps Their Hold Rating on Pfizer (PFE)

Business Insider

time2 hours ago

  • Business Insider

Bernstein Keeps Their Hold Rating on Pfizer (PFE)

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. Confident Investing Starts Here: Breen covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Pfizer, and Moderna. According to TipRanks, Breen has an average return of -0.1% and a 27.78% success rate on recommended stocks. In addition to Bernstein, Pfizer also received a Hold from Berenberg Bank's Kerry Holford in a report issued on May 29. However, on May 30, DBS maintained a Buy rating on Pfizer (NYSE: PFE). The company has a one-year high of $31.54 and a one-year low of $20.92. Currently, Pfizer has an average volume of 53.81M. Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PFE in relation to earlier this year. Most recently, in March 2025, JENNIFER B. DAMICO, the SVP & Controller of PFE sold 3,249.00 shares for a total of $84,373.90.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store